Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
MILTENYI BIOTEC ASIA PACIFIC PTE. LTD.
Class D medical device
Miltenyi Biotec B.V. & Co. KG
General Hospital
The CliniMACS® CD56 Reagent is used for the in vitro separation of human cells from heterogeneous hematologic cell populations in combination with the other components of the CliniMACS® System.
Models: CliniMACS Tubing Set LS - 162-01, CliniMACS CD56 Reagent - 271-01, CliniMACS Tubing Set - 161-01, CliniMACS plus Instrument - 151-01, CliniMACS PBS/EDTA Buffer - 700-25, CliniMACS Depletion Tubing Set - 261-01
2010-08-21